Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Increased familial risk of the psychotic phenotype of Alzheimer disease.

Sweet RA, Nimgaonkar VL, Devlin B, Lopez OL, DeKosky ST.

Neurology. 2002 Mar 26;58(6):907-11.

PMID:
11914406
2.

Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype.

Sweet RA, Nimgaonkar VL, Devlin B, Jeste DV.

Mol Psychiatry. 2003 Apr;8(4):383-92. Review.

PMID:
12740595
3.

Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.

Sweet RA, Devlin B, Pollock BG, Sukonick DL, Kastango KB, Bacanu SA, Chowdari KV, DeKosky ST, Ferrell RE.

Mol Psychiatry. 2005 Nov;10(11):1026-36.

PMID:
16027741
4.

Lack of familial aggregation of Parkinson disease and Alzheimer disease.

Levy G, Louis ED, Mejia-Santana H, Côté L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K.

Arch Neurol. 2004 Jul;61(7):1033-9.

PMID:
15262733
5.

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV.

Neurology. 2000 May 23;54(10):1965-71.

PMID:
10822438
6.

Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease.

Borroni B, Agosti C, Archetti S, Costanzi C, Bonomi S, Ghianda D, Lenzi GL, Caimi L, Di Luca M, Padovani A.

Neurosci Lett. 2004 Nov 11;370(2-3):127-9.

PMID:
15488308
7.

Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype.

Perez-Madriñan G, Cook SE, Saxton JA, Miyahara S, Lopez OL, Kaufer DI, Aizenstein HJ, DeKosky ST, Sweet RA.

Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):449-56. Review.

PMID:
15353383
8.

Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.

Craig D, Hart DJ, Carson R, McIlroy SP, Passmore AP.

Neurosci Lett. 2004 Sep 16;368(1):33-6.

PMID:
15342129
9.

Alzheimer disease subjects with psychosis have increased schizotypal symptoms before dementia onset.

Eror EA, Lopez OL, Dekosky ST, Sweet RA.

Biol Psychiatry. 2005 Aug 15;58(4):325-30.

PMID:
15978552
10.

Prediction of psychosis onset in Alzheimer disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes.

Wilkosz PA, Miyahara S, Lopez OL, Dekosky ST, Sweet RA.

Am J Geriatr Psychiatry. 2006 Apr;14(4):352-60.

PMID:
16582044
11.

Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms.

Avramopoulos D, Fallin MD, Bassett SS.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):9-13.

PMID:
15389761
12.

Familial patterns of risk in very late-onset Alzheimer disease.

Silverman JM, Smith CJ, Marin DB, Mohs RC, Propper CB.

Arch Gen Psychiatry. 2003 Feb;60(2):190-7.

PMID:
12578437
13.

Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease.

Sweet RA, Nimgaonkar VL, Kamboh MI, Lopez OL, Zhang F, DeKosky ST.

Arch Neurol. 1998 Oct;55(10):1335-40. Erratum in: Arch Neurol 2002 Jun;59(6):1042.

PMID:
9779662
14.

Genetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease.

Di Maria E, Bonvicini C, Bonomini C, Alberici A, Zanetti O, Gennarelli M.

J Alzheimers Dis. 2009;18(4):953-60. doi: 10.3233/JAD-2009-1194.

PMID:
20009237
15.

Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.

Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA.

Arch Neurol. 2002 Apr;59(4):594-600.

PMID:
11939894
16.

Psychotic symptoms in Alzheimer disease: evidence for subtypes.

Cook SE, Miyahara S, Bacanu SA, Perez-Madriñan G, Lopez OL, Kaufer DI, Nimgaonkar VL, Wisniewski SR, DeKosky ST, Sweet RA.

Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):406-13.

PMID:
12837669
17.

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.

Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.

Int J Geriatr Psychiatry. 2007 May;22(5):475-84.

PMID:
17471598
18.

Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease.

Borroni B, Grassi M, Agosti C, Archetti S, Costanzi C, Cornali C, Caltagirone C, Caimi L, Di Luca M, Padovani A.

Am J Geriatr Psychiatry. 2006 Apr;14(4):343-51.

PMID:
16582043
19.

The relationship between delusions and depression in Alzheimer's disease.

Bassiony MM, Warren A, Rosenblatt A, Baker A, Steinberg M, Steele CD, Sheppard JM, Lyketsos CG.

Int J Geriatr Psychiatry. 2002 Jun;17(6):549-56.

PMID:
12112179
20.

Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.

Borroni B, Grassi M, Costanzi C, Zanetti M, Archetti S, Franzoni S, Caimi L, Padovani A.

Neurobiol Aging. 2007 Aug;28(8):1231-8.

PMID:
16837108
Items per page

Supplemental Content

Support Center